Barclays lowered the firm’s price target on Molina Healthcare (MOH) to $186 from $270 and keeps an Equal Weight rating on the shares following the Q2 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Molina Healthcare price target lowered to $179 from $373 at Baird
- Cantor downgrades Molina to Neutral on Medicaid uncertainty
- Molina Healthcare Reports Q2 2025 Financial Results
- Molina Healthcare Earnings Call: Mixed Sentiment Amid Growth
- Molina Healthcare downgraded to Neutral from Overweight at Cantor Fitzgerald